Immunological Evaluation of Co-Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidates

被引：23

作者：

Aiga, Taku ^{[1
]}

Manabe, Yoshiyuki ^{[1
,2
]}

Ito, Keita ^{[1
,2
]}

Chang, Tsung-Che ^{[1
]}

Kabayama, Kazuya ^{[1
,2
]}

Ohshima, Shino ^{[3
]}

Kametani, Yoshie ^{[3
]}

Miura, Ayane ^{[1
]}

Furukawa, Hiroto ^{[4
]}

Inaba, Hiroshi ^{[4
]}

Matsuura, Kazunori ^{[4
]}

Fukase, Koichi ^{[1
,2
]}

机构：

[1] Osaka Univ, Grad Sch Sci, Dept Chem, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan

[2] Osaka Univ, Project Res Ctr Fundamental Sci, Grad Sch Sci, Core Med & Sci Collaborat Res & Educ, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan

[3] Tokai Univ, Sch Med, Isehara, Kanagawa 2591193, Japan

[4] Tottori Univ, Ctr Res Green Sustainable Chem, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyama Minami, Tottori 6808552, Japan

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2020年 / 59卷 / 40期

关键词：

adjuvants; antigens; cancer; peptides; self-assembly; ROBUST IMMUNE-RESPONSES; CLINICAL-TRIAL; ALPHA-GALACTOSYLCERAMIDES; LIPOPEPTIDE ADJUVANTS; MITOGENIC PRINCIPLE; CONJUGATE VACCINES; CELL-ACTIVATION; RECOGNITION; AGONIST; MUC1;

D O I：

10.1002/anie.202007999

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Co-assembling vaccines composed of a lipidated HER2-derived antigenic CH401 peptide and either a lipophilic adjuvant, Pam(3)CSK(4), alpha-GalCer, or lipid A 506, were evaluated as breast cancer vaccine candidates. This vaccine design was aimed to inherit both antigen multivalency and antigen-specific immunostimulation properties, observed in reported self-adjuvanting vaccine candidates, by using self-assembly and adjuvant-conjugated antigens. Under vaccination concentrations, respective lipophilic adjuvants underwent co-assembly with lipidated CH401, which boosted the anti-CH401 IgG and IgM production. In particular, alpha-GalCer was responsible for the most significant immune activation. Therefore, the newly developed vaccine design enabled the optimization of adjuvants against the antigenic CH401 peptide in a simple preparatory manner. Overall, the co-assembling vaccine design opens the door for efficient and practical self-adjuvanting vaccine development.

引用

页码：17705 / 17711

页数：7

共 74 条

[1] Linked Toll-Like Receptor Triagonists Stimulate Distinct, Combination-Dependent Innate Immune Responses [J].

Albin, Tyler J. ;

Tom, Janine K. ;

Manna, Saikat ;

Gilkes, Adrienne P. ;

Stetkevich, Samuel A. ;

Katz, Benjamin B. ;

Supnet, Medalyn ;

Felgner, Jiin ;

Jain, Aarti ;

Nakajima, Rie ;

Jasinskas, Algis ;

Zlotnik, Albert ;

Pearlman, Eric ;

Davies, D. Huw ;

Felgner, Phillip L. ;

Burkhardt, Amanda M. ;

Esser-Kahn, Aaron P. .

ACS CENTRAL SCIENCE, 2019, 5 (07) :1137-1145

[2] NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity [J].

Anderson, Regan J. ;

Compton, Benjamin J. ;

Tang, Ching-wen ;

Authier-Hall, Astrid ;

Hayman, Colin M. ;

Swinerd, Gene W. ;

Kowalczyk, Renata ;

Harris, Paul ;

Brimble, Margaret A. ;

Larsen, David S. ;

Gasser, Olivier ;

Weinkove, Robert ;

Hermans, Ian F. ;

Painter, Gavin F. .

CHEMICAL SCIENCE, 2015, 6 (09) :5120-5127

[3] Roles of NKT cells in cancer immunotherapy [J].

Bae, Eun-Ah ;

Seo, Hyungseok ;

Kim, Il-Kyu ;

Jeon, Insu ;

Kang, Chang-Yuil .

ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (07) :543-548

[4] Branched and linear lipopeptide vaccines have different effects on primary CD4+ and CD8+ T-cell activation but induce similar tumor-protective memory CD8+ T-cell responses [J].

Baz, Adriana ;

Buttigieg, Kathy ;

Zeng, Weiguang ;

Rizkalla, Michael ;

Jackson, David C. ;

Groves, Penny ;

Kelso, Anne .

VACCINE, 2008, 26 (21) :2570-2579

[5] Lipopeptide vaccines - yesterday, today, and tomorrow [J].

BenMohamed, L ;

Wechsler, SL ;

Nesburn, AB .

LANCET INFECTIOUS DISEASES, 2002, 2 (07) :425-431

[6] THE MITOGENIC PRINCIPLE OF ESCHERICHIA-COLI LIPOPROTEIN - B-LYMPHOCYTE MITOGENICITY OF THE SYNTHETIC ANALOG PALMITOYL-TETRAPEPTIDE (PAM-SER-SER-ASN-ALA) [J].

BESSLER, WG ;

COX, M ;

WIESMULLER, KH ;

JUNG, G .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 121 (01) :55-61

[7] Fully Synthetic Self-Adjuvanting Thioether-Conjugated GlycopeptideLipopeptide Antitumor Vaccines for the Induction of Complement-Dependent Cytotoxicity against Tumor Cells [J].

Cai, Hui ;

Sun, Zhan-Yi ;

Huang, Zhi-Hua ;

Shi, Lei ;

Zhao, Yu-Fen ;

Kunz, Horst ;

Li, Yan-Mei .

CHEMISTRY-A EUROPEAN JOURNAL, 2013, 19 (06) :1962-1970

[8] Results of the First Phase 1 Clinical Trial of the HER-2/neu Peptide (GP2) Vaccine in Disease-Free Breast Cancer Patients [J].

Carmichael, Mark G. ;

Benavides, Linda C. ;

Holmes, Jarrod P. ;

Gates, Jeremy D. ;

Mittendorf, Elizabeth A. ;

Ponniah, Sathibalan ;

Peoples, George E. .

CANCER, 2010, 116 (02) :292-301

[9]

Cavallari M, 2014, NAT CHEM BIOL, V10, P950, DOI [10.1038/NCHEMBIO.1650, 10.1038/nchembio.1650]

[10]

Chang T. C., 2018, ANGEW CHEM, V130, P8351

← 1 2 3 4 5 6 7 8 →